Anand Kiran Parikh - 22 Jun 2026 Form 4 Insider Report for Faeth Therapeutics, Inc. (SNSE)

Reporting relationship: President and CEO, Director
Issuer ticker: SNSE
Reported as of: 22 Jun 2026
Net transaction value: +$55,447
SEC form: 4
Accepted by SEC: 24 Jun 2026, 18:55:32 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Josiah Craver, Attorney-in-Fact

Key filing fact

Anand Kiran Parikh filed Form 4 for Faeth Therapeutics, Inc. (SNSE) on 24 Jun 2026.

Key facts

This page summarizes Anand Kiran Parikh's Form 4 filing for Faeth Therapeutics, Inc. (SNSE).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Jun 2026, 18:55.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: +$55,447.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111813 Primary reporting owner

Parikh Anand Kiran

Relationship: President and CEO, Director
Address: C/O FAETH THERAPEUTICS, INC., 701 TILLERY STREET #12 #1010, AUSTIN
Signature: /s/ Josiah Craver, Attorney-in-Fact
Signature date: 24 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNSE transaction

Common Stock

Purchase

Transaction value: $55,447
Shares: +2,806
Change %: +0.37%
Price: $19.76
Shares after: 764,234
Date: 22 Jun 2026
Ownership: Direct

SNSE transaction

Common Stock

Options Exercise

Transaction value
Shares: +45,252
Change %: +5.9%
Price: $1.16^*
Shares after: 809,486
Date: 22 Jun 2026
Ownership: Direct

SNSE transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,213
Change %: +1%
Price: $1.16^*
Shares after: 817,699
Date: 22 Jun 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNSE transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -45,252
Change %: -33%
Price: $0.000000^*
Shares after: 91,632
Date: 22 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,252
Exercise price: $1.16
Footnotes: F1, F2

SNSE transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -8,213
Change %: -67%
Price: $0.000000^*
Shares after: 4,107
Date: 22 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,213
Exercise price: $1.16
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Beginning on March 1, 2026, 12,258 shares vest monthly through January 1, 2027, with the balance fully vesting on February 1, 2027.

Footnote F2

The Form 4/A filed on June 16, 2026 (the "Form 4/A") contained a clerical error with respect to the expiration date of the reported security. This Form 4 corrects that clerical error to report the expiration date of the reported security as December 1, 2035. All other information reported on the Form 4/A remains unchanged.

Footnote F3

Beginning August 1, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.